X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2372) 2372
Book Review (265) 265
Publication (142) 142
Newsletter (86) 86
Conference Proceeding (28) 28
Book Chapter (6) 6
Dissertation (2) 2
Magazine Article (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
verteporfin (1922) 1922
index medicus (1838) 1838
ophthalmology (1741) 1741
humans (1646) 1646
photodynamic therapy (1468) 1468
macular degeneration (1150) 1150
male (1126) 1126
female (1116) 1116
aged (977) 977
middle aged (827) 827
photochemotherapy (803) 803
fluorescein angiography (789) 789
ranibizumab (770) 770
treatment outcome (662) 662
choroidal neovascularization - drug therapy (654) 654
aged, 80 and over (595) 595
choroidal neovascularization (571) 571
retrospective studies (532) 532
bevacizumab (529) 529
tomography, optical coherence (523) 523
photosensitizing agents - therapeutic use (515) 515
visual acuity (498) 498
porphyrins - therapeutic use (487) 487
visual acuity - physiology (474) 474
age-related macular degeneration (472) 472
follow-up studies (453) 453
macular degeneration - drug therapy (440) 440
vascular endothelial growth factor a - antagonists & inhibitors (439) 439
choroidal neovascularization - etiology (421) 421
cancer (406) 406
intravitreal injections (396) 396
angiogenesis inhibitors - therapeutic use (395) 395
neovascularization (374) 374
adult (362) 362
subfoveal choroidal neovascularization (327) 327
prospective studies (321) 321
care and treatment (304) 304
macular degeneration - complications (300) 300
antibodies, monoclonal, humanized (294) 294
vascular endothelial growth factor (283) 283
eye diseases (278) 278
choroidal neovascularization - physiopathology (274) 274
angiogenesis inhibitors - administration & dosage (271) 271
photochemotherapy - methods (268) 268
optical coherence tomography (267) 267
research (254) 254
endothelial growth-factor (251) 251
verteporfin photodynamic therapy (241) 241
injections (229) 229
medical imaging (221) 221
indocyanine green (218) 218
choroidal neovascularization - diagnosis (215) 215
verteporfin therapy (215) 215
randomized clinical-trial (214) 214
physiological aspects (212) 212
polypoidal choroidal vasculopathy (208) 208
medicine & public health (198) 198
vitreous body (191) 191
choroid - blood supply (188) 188
injection (185) 185
abridged index medicus (184) 184
animals (184) 184
intravitreal bevacizumab (180) 180
macular degeneration - physiopathology (180) 180
retina (169) 169
antibodies, monoclonal - therapeutic use (166) 166
efficacy (160) 160
genetic structures (158) 158
secondary (158) 158
therapy (158) 158
coloring agents (155) 155
age (153) 153
antibodies, monoclonal - administration & dosage (153) 153
wet macular degeneration - drug therapy (152) 152
antibodies, monoclonal, humanized - therapeutic use (150) 150
analysis (147) 147
pathological myopia (144) 144
visual acuity - drug effects (142) 142
diabetic retinopathy (140) 140
combined modality therapy (137) 137
studies (137) 137
retreatment (136) 136
avastin (135) 135
laser photocoagulation (134) 134
time factors (132) 132
central serous chorioretinopathy (129) 129
patients (129) 129
indocyanine green angiography (126) 126
safety (126) 126
antibodies, monoclonal, humanized - administration & dosage (125) 125
macular degeneration - diagnosis (125) 125
surgery (123) 123
pharmacology & pharmacy (120) 120
fundus oculi (115) 115
photosensitizing agents - administration & dosage (115) 115
sense organs (114) 114
drug therapy (112) 112
degeneration (110) 110
visual-acuity (110) 110
choroid diseases - drug therapy (109) 109
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2303) 2303
German (84) 84
French (52) 52
Korean (15) 15
Spanish (6) 6
Turkish (6) 6
Czech (5) 5
Portuguese (4) 4
Polish (3) 3
Hungarian (2) 2
Slovenian (2) 2
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2013, Volume 120, Issue 11, pp. 2292 - 2299
Purpose To assess long-term outcomes 7 to 8 years after initiation of intensive ranibizumab therapy in exudative age-related macular degeneration (AMD)... 
Ophthalmology | EYE | OPHTHALMOLOGY | MACULAR DEGENERATION | VERTEPORFIN PHOTODYNAMIC THERAPY | NATURAL-HISTORY | BEVACIZUMAB | Macular degeneration | Care and treatment | Patient outcomes
Journal Article
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 1395 - 1395
Photodynamic therapy (PDT) is a promising cancer treatment modality that can selectively target unresectable tumors through optical activation of cytotoxic... 
CANCER | MULTIDISCIPLINARY SCIENCES | VERTEPORFIN
Journal Article
by Ho, YF and Chao, A and Chen, KJ and Chao, AN and Wang, NK and Liu, L and Chen, YP and Hwang, YS and Wu, WC and Lai, CC and Chen, TL
PLOS ONE, ISSN 1932-6203, 05/2018, Volume 13, Issue 5
Background To investigate the treatment outcomes and predictors of response to photodynamic therapy (PDT) in patients with symptomatic circumscribed hemangioma... 
VERTEPORFIN | MULTIDISCIPLINARY SCIENCES | STURGE-WEBER-SYNDROME
Journal Article
American Journal of Cancer Research, ISSN 2156-6976, 2016, Volume 6, Issue 1, pp. 27 - 37
Yes-associated protein (YAP), the central mediator of Hippo pathway, not only regulates a diversity of cellular processes during development but also plays a... 
Verteporfin | YAP | 14-3-3σ | Endometrial cancer
Journal Article
Journal Article
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, ISSN 0275-004X, 01/2008, Volume 28, Issue 1, pp. 85 - 93
Purpose: To evaluate the efficacy of a safety enhanced photodynamic therapy (PDT) protocol with half-dose verteporfin for treating chronic central serous... 
HALF DOSE VERTEPORFIN | optical coherence tomography | photodynamic therapy | verteporfin | HUMAN EYES | OPHTHALMOLOGY | MACULAR DEGENERATION | DETACHMENT | INDOCYANINE GREEN ANGIOGRAPHY | CHOROIDAL NEOVASCULARIZATION | central serous chorioretinopathy
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2014, Volume 61, Issue 5, pp. 1088 - 1096
Background & Aims Although the growth suppressing Hippo pathway has been implicated in hepatocellular carcinoma (HCC) pathogenesis, it is unknown at which... 
Gastroenterology and Hepatology | Preneoplastic stages | HCC | Verteporfin | TCPOBOP | Hippo pathway | YES-ASSOCIATED PROTEIN | RAT | ORGAN SIZE CONTROL | REGENERATION | CELL-PROLIFERATION | LESIONS | CARCINOGENESIS | PATHWAY | HEPATOCELLULAR-CARCINOMA DEVELOPMENT | GASTROENTEROLOGY & HEPATOLOGY | TUMORIGENESIS | Adenoma, Liver Cell - drug therapy | Precancerous Conditions - etiology | Adenoma, Liver Cell - etiology | Humans | Middle Aged | Rats, Inbred F344 | Male | MicroRNAs - metabolism | Precancerous Conditions - metabolism | Phosphoproteins - metabolism | Liver Neoplasms - etiology | Precancerous Conditions - drug therapy | Young Adult | Liver Neoplasms, Experimental - metabolism | Carcinoma, Hepatocellular - drug therapy | Apoptosis Regulatory Proteins - genetics | Adult | Female | Antineoplastic Agents - pharmacology | Carcinoma, Hepatocellular - etiology | Protein-Serine-Threonine Kinases - metabolism | Gene Expression | Signal Transduction | Adenoma, Liver Cell - metabolism | Liver Neoplasms - drug therapy | Rats | Porphyrins - pharmacology | Liver Neoplasms, Experimental - etiology | Apoptosis Regulatory Proteins - metabolism | Animals | Liver Neoplasms, Experimental - drug therapy | Apoptosis Regulatory Proteins - antagonists & inhibitors | Liver Neoplasms - metabolism | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | Mice | MicroRNAs - genetics | Adaptor Proteins, Signal Transducing - metabolism | Carcinoma, Hepatocellular - metabolism | Liver cancer | Health aspects | Index Medicus
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 07/2018, Volume 136, Issue 7, pp. 786 - 793
IMPORTANCE Polypoidal choroidal vasculopathy (PCV) is common in Asian populations, but an optimal treatment approach remains to be confirmed. OBJECTIVE To... 
OPHTHALMOLOGY | MACULAR DEGENERATION | VERTEPORFIN PHOTODYNAMIC THERAPY | SHORT-TERM EFFICACY | COMBINATION | RANIBIZUMAB | Online First | Original Investigation | Research
Journal Article
OPHTHALMOLOGY, ISSN 0161-6420, 08/2010, Volume 117, Issue 8, pp. 1662 - 1664
Journal Article
Oncotarget, ISSN 1949-2553, 03/2019, Volume 10, Issue 19, pp. 1798 - 1811
Despite the introduction of tyrosine kinase inhibitors, gastrointestinal stromal tumors (GIST) resistance remains a major clinical challenge. We previously... 
Journal Article
Ophthalmology, ISSN 0161-6420, 2016, Volume 123, Issue 3, pp. 617 - 624
Purpose To investigate changes in subfoveal choroidal thickness after intravitreal aflibercept injections (IAIs) for neovascular age-related macular... 
Ophthalmology | VERTEPORFIN | OPTICAL COHERENCE TOMOGRAPHY | HEALTHY-SUBJECTS | OPHTHALMOLOGY | DIURNAL-VARIATION | VEGF TRAP-EYE | RANIBIZUMAB | VASCULOPATHY | Macular degeneration | Care and treatment
Journal Article
Ophthalmology, ISSN 0161-6420, 10/2018, Volume 125, Issue 10, pp. 1547 - 1555
Purpose: To compare the anatomic and functional efficacy and safety of half-dose photodynamic therapy (PDT) versus high-density subthreshold micropulse laser... 
VERTEPORFIN | FLUENCE | OPHTHALMOLOGY | MACULAR DEGENERATION | FOLLOW-UP | 577 NM | CHOROIDAL NEOVASCULARIZATION | Clinical trials | Photochemotherapy | Cancer | Lasers in medicine | Index Medicus
Journal Article
Journal of Porphyrins and Phthalocyanines, ISSN 1088-4246, 04/2018, Volume 22, Issue 4, pp. 342 - 354
The self-aggregation process and its overcoming remain a barrier for the employment of many molecules as photosensitizers (PS) in photodynamic therapy (PDT).... 
Verteporfin | computational analysis | NOESY | polymeric micelles | photodynamic therapy | ACID | PHOTOSENSITIZERS | WATER/ETHANOL MIXTURES | Verteporfin (R) | MICELLES | PHOTOPHYSICAL PROPERTIES | PORPHYRIN | CHEMISTRY, MULTIDISCIPLINARY | SPECTROSCOPY | MULTIVARIATE-ANALYSIS | PK(A)
Journal Article
European Journal of Ophthalmology, ISSN 1120-6721, 07/2017, Volume 27, Issue 4, pp. 470 - 475
Purpose: To evaluate retreatment indications/morphologic responses to ranibizumab monotherapy and combination with verteporfin photodynamic therapy (PDT).... 
Verteporfin | Age-related macular degeneration | Combined therapy | Ranibizumab | VERTEPORFIN PLUS RANIBIZUMAB | OPHTHALMOLOGY | MACULAR DEGENERATION | CHOROIDAL NEOVASCULARIZATION
Journal Article
Ophthalmology, ISSN 0161-6420, 2012, Volume 119, Issue 12, pp. 2537 - 2548
Journal Article